Caplight Directory>Investors>Thuja Capital>Thujacapital


Thuja Capital

Thuja Capital

Utrecht, Utrechtthujacapital.com

Overview

Thuja Capital is an independent venture capital firm specialized in investing in early-stage medical product companies in the Netherlands and Belgium. The firm seeks to invest in medical devices, medical technology, diagnostics, therapeutics, medical foods & nutraceuticals, and digital health sectors. It aims is to leverage science with entrepreneurship and capital, in order to accelerate innovative, affordable medical products to patients.

Year Founded

2006

Portfolio Companies

13

Investments

CompanyDateStageLead
TacalyxApr 2026SeedCo-investor
ATRO MedicalFeb 2026Early FundingCo-investor
Pan Cancer TDec 2025Early FundingCo-investor
Salvia BioElectronicsMay 2025Series BCo-investor
Alesta TherapeuticsJan 2025Series ACo-investor
View all investments

Key People

Michel Briejer

Managing Partner

Florian Ludwig

Venture Partner

Eline van Beest

Operational Partner

Tyler F. Hayes

Principal

Nawal Bahia El I.

Member Of The Investor Board (TCHF III)

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersUtrecht, Utrecht
Year Founded2006

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.